CEO Stephen Sinclair says profitability and break even is certainly on the radar, although no timeline given.
Newly-listed tech company reports higher revenue but wider loss for FY22.
Potential buyers are believed to have made indicative bids and are now going though due diligence.
Pharmacy operating profit up 49% in 2022.
Rakon lifted its profit 244%, helped by semiconductor chip shortage.
Although large events and claims inflation continue to weigh.
Telematics company embarks on growth phase but still searching for new CEO.
Net profit up 244% at the NZX-listed components business.
Covid restrictions worse than anticipated in healthcare sector.
F&P antsy about providing financial forecasts.
